Pre Market Analysis: Dalal Street may open lower; ITC, Glenmark Pharma and G R Infraprojects in news today

Market Opening - An Overview

Nifty futures on the Singapore Exchange were trading 0.14% lower 17,308, signalling that Dalal Street was headed for a negative start on Wednesday.

Asian shares were mixed in early trade on Wednesday as investors were in the sidelines awaiting the Fed’s monetary policy decision. Japan’s Nikkei was down 0.08%, Topix rose 0.37%, Hang Seng was up 0.26% and CSI 300 fell 0.29%.

Indian rupee fell 10 paise to 75.87 against the US dollar on Tuesday.

FII/DII Trading Data on Tuesday (14-12-2021)

CategoryBuy ValueSell ValueNet Value
*All numbers are in INR crore

Stocks in News Today

ITC: The company’s chairman Sanjiv Puri talked about demerger possibilities for the FMCG business and listing infotech business at ITC’s first institutional investors and financial analysts meeting. He also discussed the demerger plans of its hotel business and said the company will take action once the hospitality industry recovers.

Glenmark Pharmaceuticals: The company’s subsidiary Ichnos Sciences has licensed the commercialisation rights of a monoclonal antibody for autoimmune diseases to Almirall for €20.8 million (around Rs 180 crore). Under the agreement, Almirall has the global rights to develop and commercialize the monoclonal antibody for autoimmune diseases, while Ichnos will retain rights for antibodies acting on the IL-1RAP pathway for oncology indications.

G R Infraprojects: The company said the project “Development of Purvanchal Expressway (Package-IV) from Sidhi Ganeshpur to Sansarpur in Uttar Pradesh on EPC basis” has been provisionally completed. Subsidiaries GR Amritsar Bathinda Highway Private Limited and GR Ludhiana Rupnagar Highway Private Limited have executed the concession agreement with the National Highways Authority of India on December 14.

SMS Lifesciences India: The company has executed a share purchase agreement and share-subscription agreement with ChemWerth Inc. USA, for divestment up to 10% shareholding in Mahi Drugs, and raising fresh equity in Mahi Drugs, on a private placement basis.

Mold-Tek Packaging: The company has launched Qualified institutional placement (QIP) issue on December 14 and approved the floor price of Rs 722.40 per equity share for the QIP.